A guide to when they start working, patient experiences, how long the benefits last — and what to know about Tezepelumab
Biologic treatments — like omalizumab, mepolizumab, benralizumab, dupilumab, and now tezepelumab — have transformed care for people with severe asthma and related lung conditions. But many patients naturally ask:
-
When will I start to feel better?
-
Will the benefit last?
-
Am I eligible for this treatment?
-
What if it wears off or I stop taking it?
-
Which biologic is right for me?
💷 Access to Biologics: Who Can Have Them?
Biologics are highly effective — but they are also expensive treatments, often costing £10,000–£30,000 per year. Because of this, the NHS only offers them to patients who meet strict criteria.
This helps ensure:
-
Fair access
-
Best use of NHS resources
-
That patients are likely to benefit
✅ To qualify for a biologic, patients must typically:
-
Have confirmed severe asthma
-
Symptoms remain poorly controlled despite taking:
-
High-dose inhaled steroids (ICS)
-
Long-acting beta agonists (LABAs)
-
Other controller medication (e.g. montelukast)
-
-
-
Have frequent asthma attacks
-
Usually 2 or more flare-ups in the past year needing:
-
Oral steroids (e.g. prednisolone)
-
A&E or hospital care
-
-
-
Be using their inhalers properly and regularly
-
Doctors will check that medication is being taken as prescribed
-
Inhaler technique must be correct
-
Other problems (like reflux or anxiety) must be addressed first
-
-
Have the right blood or allergy profile
(This depends on which biologic is being considered):
| Biologic | Biomarker Criteria |
|---|---|
| Omalizumab | IgE in range + allergic asthma |
| Mepolizumab/Benralizumab | Eosinophils ≥150–300 cells/µL |
| Dupilumab | Raised FeNO or IgE, plus eosinophilic features |
| Tezepelumab | Works in a wider group, including low eosinophils |
-
Be assessed by a specialist team
-
Biologics are only prescribed after a full multidisciplinary review in a specialist asthma service
-
🔄 After Starting:
-
Patients are reviewed after 3–6 months
-
If there’s no improvement, treatment is stopped
-
Continued use depends on measurable benefit, such as:
-
Fewer attacks
-
Reduced steroid need
-
Better lung function or asthma control scores
-
💬 “Biologics are not a quick fix — but when matched carefully, they can be life-changing.”
⏳ When Will I Start Feeling Better?
Most patients begin to feel some improvement within the first few weeks to three months.
🟩 What Other Patients Say:
-
Lynn (USA):
“Within five days, I could tell … I was not coughing as much.”
-
Mena, 17 (USA):
“She doesn’t have to rely on steroids as much.”
“Now I’m stable.” -
Catherine, 88 (UK):
“Since taking biologics, I’ve not had to call the office about breathing problems once.”
-
UK Patient Survey:
“Biologic treatment stopped the disruption of family and social life.”
“Energy and mental health improved by 3 months.”
📈 Typical Timeline of Benefits:
| Time After Starting | What You May Notice |
|---|---|
| 1–2 weeks | Less coughing, better sleep, reduced night symptoms |
| 2–4 weeks | Easier breathing, less tightness, more energy |
| 1–3 months | Fewer flare-ups, less need for oral steroids |
| 3–6 months | Improved walking, daily life, and lung test scores |
| 12 months | Full review of benefit — continued if effective |
📆 How Long Do the Benefits Last?
If the biologic is working and you stay on treatment, the benefits can last for years:
-
Many patients remain stable for 1–5 years or more
-
Biologics are ongoing treatments — not cures, but long-term control
-
If stopped, some patients stay well for a time, while others relapse
💡 Spotlight on Tezepelumab (Tezspire)
Tezepelumab is a newer biologic that works differently from the others — it targets TSLP, an upstream trigger of inflammation. This makes it suitable for a broader range of asthma patients, including those without high eosinophils or obvious allergies.
🔹 How It Works:
-
Blocks TSLP (thymic stromal lymphopoietin) — a key driver of inflammation
-
Works across multiple asthma types (eosinophilic, allergic, non-allergic)
🔹 Dosing:
-
210 mg injection every 4 weeks (subcutaneous)
🔹 Benefits (NAVIGATOR & DESTINATION trials):
-
Reduces asthma attacks by 56% regardless of eosinophil count or allergic status
-
Improvement often seen within 2–4 weeks, with continued benefit over 1–2 years
-
Long-term studies show sustained effectiveness and good safety
-
After stopping, inflammation gradually returns but may remain better than baseline for a while
🧠 Tezepelumab is especially promising for patients who haven’t responded well to other biologics, or who don’t fit into the eosinophilic or allergic categories.
✅ In Summary:
| Question | Typical Answer |
|---|---|
| When will I feel better? | 2–12 weeks, sometimes faster |
| How long does it last? | Months to years if treatment continues |
| What if I stop? | Symptoms may return gradually |
| Who can get a biologic? | Patients meeting NHS criteria, reviewed by specialists |
| Tezepelumab use? | For broad asthma types, including low-eosinophil asthma |
Share this post
Latest News posts
Fungal vaccine developments
March 22, 2023
Asthma UK’s End the Lung Health Lottery
March 21, 2023
Secondary Adrenal Insufficiency
March 17, 2023
IgG and IgE explained
March 14, 2023
Spring COVID Booster
March 8, 2023
Accessing GP services
March 8, 2023
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
